Pillstats
Rx only · Spray · Nasal

Sumatriptan

Brands: Tosymra · Sumatriptan

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)37418
US makers8 labelers
Packages14
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$10.35$20.71$31.06$41.42Dec 2025Apr 2026Jul 2026
$35.563
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
8
Active US suppliers
36%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

7.7K15K23K31K2025 Q12025 Q22025 Q32025 Q42026 Q1
24K
Rx · 2026 Q1
155K
Units dispensed
-2%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Tonix Medicines, Inc.unknown3SUPPLYING
Lannett Company, Inc.unknown2SUPPLYING
Padagis Israel Pharmaceuticals Ltdunknown2SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
Prasco Laboratoriesunknown2SUPPLYING
Cipla USA Inc.unknown1SUPPLYING
Florida Pharmaceutical Products, LLCunknown1SUPPLYING
Upsher-Smith Laboratories, LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 8, 2025
    RESOLVEDShortage resolved: Sumatriptan Nasal Spray (Prasco Laboratories)

    Sumatriptan Nasal Spray — reported in shortage by Prasco Laboratories. Therapeutic category: Neurology.

  • Sep 8, 2025
    SHORTAGEDrug shortage: Sumatriptan Nasal Spray (Prasco Laboratories)

    Sumatriptan Nasal Spray — reported in shortage by Prasco Laboratories. Therapeutic category: Neurology.